News & Events

submenu
December 12, 2014

On Dec. 11, 2014, Bob Vince won the Impact Award for his development of the ground-breaking AIDS drug, Ziagen. At the ceremony, Made in Minnesota: Celebrating University Innovators, President Kaler awarded Prof. Vince with a trophy for his innovative work. This inaugural award was given by the Office of Vice President Research (OVPR).

In the video below Prof. Vince discusses his innovation. 

February 18, 2014

Even though sun damage may be the furthest thing from your mind right now, don’t let the cool weather fool you. Irreversible skin damage can happen all year round and excessive exposure to the damaging ultraviolet (UV) rays of the sun can have many adverse effects. So, just wear sunscreen, right? Well, here’s the kicker.

September 9, 2013

University of Minnesota researchers have found that two cancer drugs combined in pill form can be used to fight HIV. The research, published Aug. 30, still has a long road ahead before the pill can be tested on humans — a road that will take years to travel. “The road is littered with the carcasses of failed drug treatments,” said Dr. Keith Henry, director of HIV research at the Hennepin County Medical Center.

March 20, 2013

Fox News Highlights CDD Research: With threats of chemical war in Syria, a new antidote to poisonous cyanide attacksChemical weapons like anthrax, sarin, mustard and ricin often make headlines, but what about the threat of a terro

February 21, 2012

Bob VinceBob Vince can't be sure where his becoming a scientist began, but where it led changed the world. As the discoverer of carbovirs, the precursor to the AIDS drug Ziagen, Vince's contribution to humanity can't be underestimated.

February 16, 2012

Cyanide is one of the deadliest poisons around. Your body can handle a little of it, but for larger exposures an antidote is necessary. Current antidotes can work, but they're slow. That could change, however, now that three researchers at the University of Minnesota's Center for Drug Design (Profs Steve Patterson, Robert Vince and Herbert Nagasawa) have synthesized Sulfanegen, a faster-acting antidote.

February 9, 2012

CDD Invention, Sulfanegen, Being Marketed for Anti-Cyanide TherapyBased on research conducted at the Center for Drug Design (CDD), Sulfanegen, a treatment for cyanide poisoning, will be developed and marketed.